Arthritis Therapeutics Market - Table of content

Inside The Report

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

5. Key Insights

6. Global Market Analysis and Forecast, By Type

6.1. Rheumatoid Arthritis
6.2. Osteoarthritis
6.3. Psoriatic Arthritis
6.4. Gout
6.5. Others

7. Global Market Analysis and Forecast, By Drug Class

7.1. TNF Inhibitors
7.2. Interleukin Inhibitors
7.3. NSAIDs
7.4. Corticosteroids
7.5. Xanthine Oxidase Inhibitors
7.6. Others

8. Global Market Analysis and Forecast, By Route of Administration

8.1. Oral
8.2. Parenteral
8.3. Topical

9. Global Market Analysis and Forecast, By Distribution Channel

9.1. Hospital Pharmacies
9.2. Retail Pharmacies
9.3. Online Pharmacies

10. Global Market Analysis and Forecast, By Region

10.1. North America
10.2. Europe
10.3. Asia Pacific
10.4. Latin America
10.5. Middle East & Africa

11. North America Market Analysis and Forecast

12. Europe Market Analysis and Forecast

13. Asia Pacific Market Analysis and Forecast

14. Latin America Market Analysis and Forecast

15. Middle East & Africa Market Analysis and Forecast

16. Competition Landscape

16.1. Novartis AG
16.2. Eli Lilly and Company
16.3. Amgen, Inc.
16.4. Merck & Co., Inc.
16.5. Bristol-Myers Squibb Company
16.6. Pfizer, Inc.
16.7. AbbVie, Inc.
16.8. Janssen Global Services, LLC (Johnson & Johnson)
16.9. F. Hoffmann-La Roche Ltd
16.10. Sanofi

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 02: Global Market Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 03: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027

Table 04: Global Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 05: Global Market Value (US$ Mn) Forecast, by Region, 2017 to 2027

Table 06: North America Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 07: North America Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 08: North America Value (US$ Mn) Forecast, by Route of Administration,

Table 09: North America Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 10: North America Market Value (US$ Mn) Forecast, By Country/Sub-region , 2017 to 2027

Table 11: Europe Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 12: Europe Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 13: Europe Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027

Table 14: Europe Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 15: Europe Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027

Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 17: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 18: Asia Pacific Market Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027

Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027

Table 21: Latin America Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 22: Latin America Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 23: Latin America Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027

Table 24: Latin America Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 25: Latin America Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027

Table 26: Middle East & Africa Value (US$ Mn) Forecast, by Type, 2017 to 2027

Table 27: Middle East & Africa Value (US$ Mn) Forecast, by Drug Class, 2017 to 2027

Table 28: Middle East & Africa Value (US$ Mn) Forecast, by Route of Administration, 2017 to 2027

Table 29: Middle East & Africa Market Value (US$ Mn) Forecast, by Distribution Channel, 2017 to 2027

Table 30: Middle East & Africa Market Value (US$ Mn) Forecast, By Country/Sub-region, 2017 to 2027

List of Figures

Figure 01: Global Market Snapshot

Figure 02: Global Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Market Value (US$ Mn) Forecast, 2017 to 2027

Figure 04: Global Market Value Share (%), by Type (2018)

Figure 05: Global Market Value Share (%), by Route of Administration (2018)

Figure 06: Global Market Value Share (%), by Drug Class (2018)

Figure 07: Global Market Value Share (%), by Distribution Channel (2018)

Figure 08: Global Market Value Share (%), by Region (2018)

Figure 09: Global Market Value Share Analysis, by Type, 2018 and 2027

Figure 10: Global Market Attractiveness, by Type, 2019 to 2027

Figure 11: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Rheumatoid Arthritis, 2017 to 2027

Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Osteoarthritis, 2017 to 2027

Figure 13: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriatic Arthritis, 2017 to 2027

Figure 14: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Gout, 2017 to 2027

Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017 to 2027

Figure 16: Global Market Value Share Analysis, by Drug Class, 2018 and 2027

Figure 17: Global Market Attractiveness, by Drug Class, 2019 to 2027

Figure 18: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by TNF Inhibitors, 2017 to 2027

Figure 19: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Interleukin Inhibitors, 2017 to 2027

Figure 20: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2017 to 2027

Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017 to 2027

Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Xanthine Oxidase Inhibitors, 2017 to 2027

Figure 23: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017 to 2027

Figure 24: Global Market Value Share(%), by Route of Administration, 2018 and 2027

Figure 25: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral, 2017 to 2027

Figure 26: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Parenteral, 2017 to 2027

Figure 27: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017 to 2027

Figure 28: Global Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 29: Global Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 30: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2017 to 2027

Figure 31: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017 to 2027

Figure 32: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Pharmacies, 2017 to 2027

Figure 33: Global Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 34: Global Market Value Share Analysis, by Region 2018 and 2027

Figure 35: Global Market Attractiveness, by Region, 2019 to 2027

Figure 36: North America Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027

Figure 37: North America Market Value Share (%), by Type, 2018 and 2027

Figure 38: North America Market Attractiveness, by Type, 2019 to 2027

Figure 39: North America Market Value Share (%), by Drug Class, 2018 and 2027

Figure 40: North America Market Attractiveness, by Drug Class, 2019 to 2027

Figure 41: North America Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 42: North America Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 43: North America Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 44: North America Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 45 : North America Market Value Share (%), By Country/Sub-region , 2018 and 2027

Figure 46: North America Market Attractiveness, By Country/Sub-region , 2019 to 2027

Figure 47: Europe Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027

Figure 48: Europe Market Value Share (%), by Type, 2018 and 2027

Figure 49: Europe Market Attractiveness, by Type, 2019 to 2027

Figure 50: Europe Market Value Share (%), by Drug Class, 2018 and 2027

Figure 51: Europe Market Attractiveness, by Drug Class, 2019 to 2027

Figure 52: Europe Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 53: Europe Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 54: Europe Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 55: Europe Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 56: Europe Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 57: Europe Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027

Figure 58: Asia Pacific Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027

Figure 59: Asia Pacific Market Value Share (%), by Type, 2018 and 2027

Figure 60: Asia Pacific Market Attractiveness, by Type, 2019 to 2027

Figure 61: Asia Pacific Market Value Share (%), by Drug Class, 2018 and 2027

Figure 62: Asia Pacific Market Attractiveness, by Drug Class, 2019 to 2027

Figure 63: Asia Pacific Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 64: Asia Pacific Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 65: Asia Pacific Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 66: Asia Pacific Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 67 : Asia Pacific Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 68: Asia Pacific Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027

Figure 69: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017 to 2027

Figure 70: Latin America Market Value Share (%), by Type, 2018 and 2027

Figure 71: Latin America Market Attractiveness, by Type, 2019 to 2027

Figure 72: Latin America Market Value Share (%), by Drug Class, 2018 and 2027

Figure 73: Latin America Market Attractiveness, by Drug Class, 2019 to 2027

Figure 74: Latin America Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 75: Latin America Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 76: Latin America Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 77: Latin America Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 78 : Latin America Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Figure 79: Latin America Market Attractiveness, By Country/Sub-region /Sub-region, 2019 to 2027

Figure 80: Middle East & Africa Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017 to 2027

Figure 81: Middle East & Africa Market Value Share (%), by Type, 2018 and 2027

Figure 82: Middle East & Africa Market Attractiveness, by Type, 2019 to 2027

Figure 83: Middle East & Africa Market Value Share (%), by Drug Class, 2018 and 2027

Figure 84: Middle East & Africa Market Attractiveness, by Drug Class, 2019 to 2027

Figure 85: Middle East & Africa Market Value Share (%), by Route of Administration, 2018 and 2027

Figure 86: Middle East & Africa Market Attractiveness, by Route of Administration, 2019 to 2027

Figure 87: Middle East & Africa Market Value Share (%), by Distribution Channel, 2018 and 2027

Figure 88: Middle East & Africa Market Attractiveness, by Distribution Channel, 2019 to 2027

Figure 89: Middle East & Africa Market Value Share (%), By Country/Sub-region /Sub-region, 2018 and 2027

Who worked on this report

Author

S.N. Jha

Principal Consultant

Editor

Anushree Karale

Editor

Preview the report firsthand - request a free sample

Free Sample

Get the brochure for pricing and purchase details

Download PDF

Explore More

Related Reports

Somavert Drugs Market Sprycel Market Electronic Endoscopic Instruments Market Robotic Medical Imaging Systems Market Disposable Latex and Nitrile Rubber Medical Gloves Market 24-Hour Nursing Care Facilities Market